NYSE:LCI - Lannett Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$16.35 -0.40 (-2.39 %)
(As of 05/24/2018 04:00 PM ET)
Previous Close$16.35
Today's Range$16.25 - $16.90
52-Week Range$13.15 - $30.35
Volume399,593 shs
Average Volume717,552 shs
Market Capitalization$636.74 million
P/E Ratio5.72
Dividend YieldN/A
Beta2.49

About Lannett (NYSE:LCI)

Lannett logoLannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral, extended release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. It also provides its products for various medical indications comprising glaucoma, cholesterol, muscle spasm, migraine, pain management, cardiovascular, antipsychosis, gastrointestinal, urinary, bronchospasms, respiratory, gallstone, congestive heart failure, thyroid deficiency, central nervous system, and gout. In addition, the company manufactures active pharmaceutical ingredients; and markets its products under the Diamox, Lipitor, Lioresal, Fioricet, Fiorinal, Lanoxin, Prolixin, MiraLAX, Imdur, Levoxyl/Synthroid, Metadate CD, Concerta, Procardia, Prilosec, Ditropan, Protonix, Imitrex, Brethine, Tussionex, and Actigall brands. Further, it sells pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with JSP, Summit Bioscience LLC, HEC Pharm Group, and Pharma Pass II LLC. Lannett Company, Inc. was founded in 1942 and is based in Philadelphia, Pennsylvania.

Receive LCI News and Ratings via Email

Sign-up to receive the latest news and ratings for LCI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
SymbolNYSE:LCI
CUSIP51601210
Phone215-333-9000

Debt

Debt-to-Equity Ratio1.29
Current Ratio2.56
Quick Ratio1.91

Price-To-Earnings

Trailing P/E Ratio5.72
Forward P/E Ratio5.24
P/E Growth1.07

Sales & Book Value

Annual Sales$633.34 million
Price / Sales0.98
Cash Flow$4.2801 per share
Price / Cash3.82
Book Value$15.97 per share
Price / Book1.02

Profitability

EPS (Most Recent Fiscal Year)$2.86
Net Income$-580,000.00
Net Margins7.01%
Return on Equity18.64%
Return on Assets6.73%

Miscellaneous

Employees1,126
Outstanding Shares38,010,000

Lannett (NYSE:LCI) Frequently Asked Questions

What is Lannett's stock symbol?

Lannett trades on the New York Stock Exchange (NYSE) under the ticker symbol "LCI."

How were Lannett's earnings last quarter?

Lannett Co Inc (NYSE:LCI) released its earnings results on Monday, May, 7th. The company reported $0.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.76 by $0.04. The business had revenue of $174.39 million for the quarter, compared to the consensus estimate of $176.51 million. Lannett had a return on equity of 18.64% and a net margin of 7.01%. Lannett's quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.77 earnings per share. View Lannett's Earnings History.

When is Lannett's next earnings date?

Lannett is scheduled to release their next quarterly earnings announcement on Tuesday, August, 21st 2018. View Earnings Estimates for Lannett.

What price target have analysts set for LCI?

5 Wall Street analysts have issued 1 year target prices for Lannett's stock. Their predictions range from $19.00 to $25.00. On average, they anticipate Lannett's share price to reach $21.50 in the next twelve months. View Analyst Ratings for Lannett.

Who are some of Lannett's key competitors?

Who are Lannett's key executives?

Lannett's management team includes the folowing people:
  • Mr. Martin P. Galvan CPA, VP of Fin., CFO & Treasurer (Age 66)
  • Mr. Robert Ehlinger, VP of Logistics & Chief Information Officer (Age 61)
  • Mr. Kevin R. Smith, Sr. VP of Sales & Marketing (Age 58)
  • Mr. John M. Abt, VP of Quality (Age 53)
  • Mr. Arthur P. Bedrosian, Director (Age 72)

Has Lannett been receiving favorable news coverage?

Media stories about LCI stock have been trending somewhat positive on Thursday, according to Accern. The research firm ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Lannett earned a coverage optimism score of 0.17 on Accern's scale. They also gave news headlines about the company an impact score of 46.43 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.

Who are Lannett's major shareholders?

Lannett's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (10.59%), LSV Asset Management (5.44%), Frontier Capital Management Co. LLC (2.59%), Dimensional Fund Advisors LP (2.17%), Northern Trust Corp (2.12%) and Heartland Advisors Inc. (1.61%). Company insiders that own Lannett stock include Arthur P Bedrosian, David Farber, G Michael Landis, James M Maher, Patrick G Lepore, Robert Ehlinger and Timothy C Crew. View Institutional Ownership Trends for Lannett.

Which major investors are selling Lannett stock?

LCI stock was sold by a variety of institutional investors in the last quarter, including Muhlenkamp & Co. Inc., Federated Investors Inc. PA, Point72 Asset Management L.P., SG Americas Securities LLC, Barclays PLC, CLARET ASSET MANAGEMENT Corp, Dimensional Fund Advisors LP and Cubist Systematic Strategies LLC. Company insiders that have sold Lannett company stock in the last year include Arthur P Bedrosian and David Farber. View Insider Buying and Selling for Lannett.

Which major investors are buying Lannett stock?

LCI stock was acquired by a variety of institutional investors in the last quarter, including LSV Asset Management, Northern Trust Corp, KBC Group NV, Heartland Advisors Inc., BlackRock Inc., Frontier Capital Management Co. LLC, Russell Investments Group Ltd. and Mackay Shields LLC. Company insiders that have bought Lannett stock in the last two years include Arthur P Bedrosian, Patrick G Lepore and Timothy C Crew. View Insider Buying and Selling for Lannett.

How do I buy shares of Lannett?

Shares of LCI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Lannett's stock price today?

One share of LCI stock can currently be purchased for approximately $16.35.

How big of a company is Lannett?

Lannett has a market capitalization of $636.74 million and generates $633.34 million in revenue each year. The company earns $-580,000.00 in net income (profit) each year or $2.86 on an earnings per share basis. Lannett employs 1,126 workers across the globe.

How can I contact Lannett?

Lannett's mailing address is 9000 STATE ROAD, PHILADELPHIA PA, 19136. The company can be reached via phone at 215-333-9000.


MarketBeat Community Rating for Lannett (LCI)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  348 (Vote Outperform)
Underperform Votes:  272 (Vote Underperform)
Total Votes:  620
MarketBeat's community ratings are surveys of what our community members think about Lannett and other stocks. Vote "Outperform" if you believe LCI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LCI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Lannett (NYSE:LCI) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Lannett in the last 12 months. Their average twelve-month price target is $21.50, suggesting that the stock has a possible upside of 31.50%. The high price target for LCI is $25.00 and the low price target for LCI is $19.00. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.202.332.332.40
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $21.50$20.80$20.80$21.50
Price Target Upside: 31.50% upside26.06% upside15.75% upside8.70% downside

Lannett (NYSE:LCI) Consensus Price Target History

Price Target History for Lannett (NYSE:LCI)

Lannett (NYSE:LCI) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/9/2018OppenheimerReiterated RatingHoldLowView Rating Details
2/8/2018BMO Capital MarketsLower Price TargetMarket Perform ➝ Market Perform$22.00 ➝ $21.00LowView Rating Details
2/7/2018Roth CapitalSet Price TargetBuy$25.00LowView Rating Details
1/24/2018Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$21.00MediumView Rating Details
8/14/2017Deutsche BankLower Price TargetHold$23.00 ➝ $19.00MediumView Rating Details
5/3/2017Robert W. BairdReiterated RatingOutperform$18.00MediumView Rating Details
8/24/2016Raymond JamesBoost Price TargetOutperform$31.00 ➝ $43.00N/AView Rating Details
(Data available from 5/24/2016 forward)

Earnings

Lannett (NYSE:LCI) Earnings History and Estimates Chart

Earnings by Quarter for Lannett (NYSE:LCI)

Lannett (NYSE:LCI) Earnings Estimates

2018 EPS Consensus Estimate: $2.82
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.52$0.68$0.60
Q2 20182$0.76$0.82$0.79
Q3 20182$0.72$0.76$0.74
Q4 20182$0.64$0.73$0.69

Lannett (NYSE LCI) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/21/2018$0.68N/AView Earnings Details
5/7/2018Q3$0.76$0.80$176.51 million$174.39 millionViewN/AView Earnings Details
2/7/2018Q2 2018$0.86$1.06$190.92 million$184.31 millionViewListenView Earnings Details
11/6/2017Q1 2018$0.52$0.60$153.62 million$155.00 millionViewN/AView Earnings Details
8/23/2017Q4 2017$0.40$0.40$139.01 million$139.10 millionViewN/AView Earnings Details
5/2/2017Q3 2017$0.87$0.77$170.28 million$165.72 millionViewListenView Earnings Details
2/1/2017Q217$0.84$0.92$169.04 million$171.00 millionViewListenView Earnings Details
11/3/2016Q117$0.71$0.77$166.72 million$161.60 millionViewN/AView Earnings Details
8/23/2016Q416$0.59$0.73$161.55 million$168.90 millionViewListenView Earnings Details
5/3/2016Q316$0.63$0.75$160.49 million$163.70 millionViewN/AView Earnings Details
2/3/2016Q216$0.94$0.95$141.62 million$127.06 millionViewN/AView Earnings Details
11/4/2015Q116$0.89$0.99$103.90 million$106.40 millionViewN/AView Earnings Details
8/25/2015Q415$0.86$0.91$97.21 million$99.28 millionViewListenView Earnings Details
5/6/2015Q315$0.94$0.97$101.10 million$99.40 millionViewN/AView Earnings Details
2/4/2015Q215$1.06$1.21$102.95 million$114.80 millionViewN/AView Earnings Details
11/3/2014Q115$0.79$0.94$91.40 million$93.40 millionViewN/AView Earnings Details
8/27/2014Q414$0.63$0.64$79.50 million$80.60 millionViewN/AView Earnings Details
5/7/2014Q314$0.60$0.63$84.50 million$80.00 millionViewN/AView Earnings Details
2/6/2014Q214$0.39$0.46$62.21 million$67.30 millionViewN/AView Earnings Details
11/7/2013Q114$0.13$0.22$41.14 million$45.82 millionViewN/AView Earnings Details
9/10/2013Q4 2013$0.07$0.12$37.89 million$40.20 millionViewN/AView Earnings Details
5/8/2013Q3 2013$0.13$0.14$35.14 million$39.00 millionViewN/AView Earnings Details
2/7/2013Q2 2013$0.05$0.10$33.53 million$36.60 millionViewN/AView Earnings Details
11/8/2012Q113$0.05$0.07$33.76 million$35.30 millionViewN/AView Earnings Details
9/6/2012Q4 2012$0.03$0.06ViewN/AView Earnings Details
5/8/2012Q3 2012$0.04$0.05ViewN/AView Earnings Details
2/7/2012Q2 2012$0.03$0.02ViewN/AView Earnings Details
11/3/2011Q1 2012$0.01$0.03ViewN/AView Earnings Details
9/7/2011Q4 2011$0.02($0.07)ViewN/AView Earnings Details
5/11/2011Q3 2011$0.04($0.01)ViewN/AView Earnings Details
2/10/2011Q2 2011$0.01$0.09ViewN/AView Earnings Details
11/11/2010Q1 2011$0.04($0.02)ViewN/AView Earnings Details
9/13/2010Q4 2010$0.07$0.11ViewN/AView Earnings Details
5/12/2010Q3 2010$0.09$0.08ViewN/AView Earnings Details
11/9/2009Q1 2010$0.11ViewN/AView Earnings Details
9/9/2009Q4 2009$0.10ViewN/AView Earnings Details
5/12/2009Q3 2009$0.05ViewN/AView Earnings Details
2/11/2009Q2 2009$0.06ViewN/AView Earnings Details
11/13/2008Q1 2009$0.05ViewN/AView Earnings Details
9/29/2008Q4 2008($0.01)ViewN/AView Earnings Details
5/15/2008Q3 2008$0.01($0.05)ViewN/AView Earnings Details
2/8/2008Q2 2008($0.01)($0.03)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Lannett (NYSE:LCI) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Lannett (NYSE LCI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 14.72%
Institutional Ownership Percentage: 98.40%
Insider Trading History for Lannett (NYSE:LCI)
Institutional Ownership by Quarter for Lannett (NYSE:LCI)

Lannett (NYSE LCI) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/11/2018Patrick G LeporeDirectorBuy25,000$15.13$378,250.00View SEC Filing  
5/10/2018Timothy C CrewCEOBuy2,000$14.73$29,460.00View SEC Filing  
1/9/2018David FarberMajor ShareholderSell10,000$25.01$250,100.004,171,269View SEC Filing  
12/13/2017David FarberMajor ShareholderSell184$30.00$5,520.004,181,269View SEC Filing  
12/5/2017David FarberMajor ShareholderSell9,816$30.05$294,970.804,190,169View SEC Filing  
12/1/2017David FarberMajor ShareholderSell10,000$26.88$268,800.004,191,269View SEC Filing  
11/27/2017Arthur P BedrosianCEOSell578$27.45$15,866.10636,616View SEC Filing  
11/24/2017Arthur P BedrosianCEOSell50,000$26.75$1,337,500.00636,616View SEC Filing  
11/22/2017Arthur P BedrosianCEOSell42,000$25.50$1,071,000.00636,616View SEC Filing  
11/8/2017Arthur P BedrosianCEOSell7,422$25.20$187,034.40679,001View SEC Filing  
11/8/2017David FarberMajor ShareholderSell10,000$25.03$250,300.004,211,069View SEC Filing  
2/6/2017Arthur P BedrosianCEOBuy10,000$20.00$200,000.00688,909View SEC Filing  
12/2/2016David FarberMajor ShareholderSell3,800$25.00$95,000.001,937,070View SEC Filing  
9/15/2016G. Michael LandisInsiderSell4,334$32.30$139,988.206,461View SEC Filing  
9/1/2016James M MaherDirectorSell1,478$33.91$50,118.9820,320View SEC Filing  
8/31/2016G. Michael LandisInsiderSell6,786$33.41$226,720.264,580View SEC Filing  
6/23/2016Robert EhlingerVPSell37,141$25.06$930,753.4640,104View SEC Filing  
6/20/2016Robert EhlingerVPSell62,859$25.40$1,596,618.6056,268View SEC Filing  
3/1/2016Robert EhlingerVPSell69,247$25.41$1,759,566.27129,674View SEC Filing  
2/5/2016Arthur P BedrosianCEOBuy4,500$24.91$112,095.00618,016View SEC Filing  
2/5/2016David A DrabikDirectorBuy1,277$24.74$31,592.9820,500View SEC Filing  
2/5/2016Kevin SmithVPBuy1,500$24.75$37,125.0015,735View SEC Filing  
2/5/2016Martin P GalvanCFOBuy3,000$24.65$73,950.0038,397View SEC Filing  
9/15/2015Arthur P BedrosianCEOSell5,000$55.64$278,200.00604,376View SEC Filing  
9/8/2015John AbtVPBuy1,000$54.77$54,770.004,259View SEC Filing  
8/17/2015Arthur P BedrosianCEOSell5,000$52.81$264,050.00View SEC Filing  
7/15/2015Arthur P BedrosianCEOSell5,000$61.92$309,600.00View SEC Filing  
6/15/2015Arthur P BedrosianCEOSell5,000$56.31$281,550.00View SEC Filing  
5/15/2015Arthur P BedrosianCEOSell5,000$53.27$266,350.00View SEC Filing  
4/15/2015Arthur P BedrosianCEOSell5,000$69.43$347,150.00View SEC Filing  
3/16/2015Arthur P BedrosianCEOSell5,000$65.23$326,150.00View SEC Filing  
3/16/2015William SchreckCOOSell134,635$64.99$8,749,928.65View SEC Filing  
3/6/2015William SchreckCOOSell50,000$63.35$3,167,500.00View SEC Filing  
2/18/2015David A DrabikDirectorSell12,500$61.55$769,375.00View SEC Filing  
2/17/2015Arthur P BedrosianCEOSell5,000$59.89$299,450.00View SEC Filing  
2/17/2015G. Michael LandisInsiderSell11,500$58.60$673,900.00View SEC Filing  
2/13/2015Jeffrey FarberDirectorSell35,000$58.18$2,036,300.00View SEC Filing  
2/11/2015Kevin SmithVPSell109,436$56.51$6,184,228.36View SEC Filing  
2/9/2015David FarberMajor ShareholderSell2,500$55.00$137,500.00View SEC Filing  
2/9/2015Kevin SmithVPSell53,534$55.36$2,963,642.24View SEC Filing  
2/6/2015G. Michael LandisInsiderSell12,049$52.93$637,753.57View SEC Filing  
1/26/2015David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
1/15/2015Arthur P BedrosianCEOSell5,000$43.50$217,500.00View SEC Filing  
12/15/2014Arthur P BedrosianCEOSell5,000$43.81$219,050.00View SEC Filing  
12/10/2014Martin P GalvanCFOBuy1,000$42.40$42,400.00View SEC Filing  
12/8/2014Ernest SaboVPSell6,000$48.03$288,180.00View SEC Filing  
10/27/2014David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
9/16/2014Arthur P BedrosianCEOSell5,000$40.05$200,250.00View SEC Filing  
8/18/2014David FarberMajor ShareholderSell5,000$41.30$206,500.00View SEC Filing  
7/15/2014Arthur P BedrosianCEOSell5,000$47.19$235,950.00View SEC Filing  
6/23/2014David FarberMajor ShareholderSell7,500$50.00$375,000.00View SEC Filing  
6/16/2014Arthur P BedrosianCEOSell5,000$46.96$234,800.00View SEC Filing  
6/16/2014David FarberMajor ShareholderSell10,000$43.53$435,300.00View SEC Filing  
6/16/2014Paul TaveiraDirectorSell1,000$46.94$46,940.00View SEC Filing  
3/17/2014William SchreckCOOSell16,600$43.85$727,910.00217,856View SEC Filing  
3/12/2014William SchreckCOOSell55,563$43.31$2,406,433.5399,821View SEC Filing  
2/20/2014Kevin SmithVPSell64,665$45.11$2,917,038.1559,566View SEC Filing  
2/13/2014Kevin SmithVPSell20,000$40.48$809,600.0059,566View SEC Filing  
12/13/2013Arthur BedrosianCEOBuy5,000$27.85$139,250.00632,152View SEC Filing  
12/13/2013Martin GalvanCFOBuy3,000$26.90$80,700.0029,500View SEC Filing  
5/14/2013Kevin SmithVPSell24,984$11.86$296,310.24View SEC Filing  
5/13/2013Kevin SmithVPSell41,929$11.80$494,762.20View SEC Filing  
5/10/2013Ernest SaboVPSell15,000$11.29$169,350.00View SEC Filing  
3/14/2013Paul TaveiraDirectorBuy1,000$9.73$9,730.00View SEC Filing  
2/13/2013Martin P GalvanCFOBuy4,000$6.88$27,520.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Lannett (NYSE LCI) News Headlines

Source:
DateHeadline
BRIEF-Lannett Receives FDA Approval For Dronabinol CapsulesBRIEF-Lannett Receives FDA Approval For Dronabinol Capsules
www.reuters.com - May 21 at 8:27 AM
Lannett Co Inc (LCI) Given Average Recommendation of "Hold" by AnalystsLannett Co Inc (LCI) Given Average Recommendation of "Hold" by Analysts
www.americanbankingnews.com - May 20 at 5:30 PM
Gross Margin Pressures Lannett (LCI), PT To $20 - Deutsche BankGross Margin Pressures Lannett (LCI), PT To $20 - Deutsche Bank
www.streetinsider.com - May 15 at 8:45 AM
Patrick G. Lepore Purchases 25,000 Shares of Lannett Co Inc (LCI) StockPatrick G. Lepore Purchases 25,000 Shares of Lannett Co Inc (LCI) Stock
www.americanbankingnews.com - May 14 at 8:00 PM
Lannett Co Inc Forecasted to Post FY2018 Earnings of $3.10 Per Share (LCI)Lannett Co Inc Forecasted to Post FY2018 Earnings of $3.10 Per Share (LCI)
www.americanbankingnews.com - May 14 at 3:32 AM
Zacks: Brokerages Anticipate Lannett Co Inc (LCI) Will Announce Quarterly Sales of $171.93 MillionZacks: Brokerages Anticipate Lannett Co Inc (LCI) Will Announce Quarterly Sales of $171.93 Million
www.americanbankingnews.com - May 12 at 3:32 AM
Insider Buying: Lannett Co Inc (LCI) CEO Acquires 2,000 Shares of StockInsider Buying: Lannett Co Inc (LCI) CEO Acquires 2,000 Shares of Stock
www.americanbankingnews.com - May 11 at 8:39 PM
Lannett (LCI) Rating Lowered to Sell at Zacks Investment ResearchLannett (LCI) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - May 10 at 4:23 PM
 Brokerages Expect Lannett Co Inc (LCI) to Post $0.67 Earnings Per Share Brokerages Expect Lannett Co Inc (LCI) to Post $0.67 Earnings Per Share
www.americanbankingnews.com - May 10 at 4:07 PM
Lannett Target of Unusually High Options Trading (LCI)Lannett Target of Unusually High Options Trading (LCI)
www.americanbankingnews.com - May 10 at 7:40 AM
Lannett (LCI) Rating Reiterated by OppenheimerLannett (LCI) Rating Reiterated by Oppenheimer
www.americanbankingnews.com - May 9 at 5:12 PM
Lannett Companys (LCI) CEO Tim Crew on Q3 2018 Results - Earnings Call TranscriptLannett Company's (LCI) CEO Tim Crew on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - May 9 at 8:32 AM
Edited Transcript of LCI earnings conference call or presentation 7-May-18 8:30pm GMTEdited Transcript of LCI earnings conference call or presentation 7-May-18 8:30pm GMT
finance.yahoo.com - May 8 at 8:29 AM
Lannett: Fiscal 3Q Earnings SnapshotLannett: Fiscal 3Q Earnings Snapshot
finance.yahoo.com - May 8 at 8:29 AM
Lannett (LCI) Releases Quarterly  Earnings Results, Beats Estimates By $0.01 EPSLannett (LCI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS
www.americanbankingnews.com - May 7 at 6:26 PM
Health Care Sector Update for 05/07/2018: LCI,ENDP,EARS,VRX,VRX.TO,NVAXHealth Care Sector Update for 05/07/2018: LCI,ENDP,EARS,VRX,VRX.TO,NVAX
www.nasdaq.com - May 7 at 5:28 PM
Earnings Reaction History: Lannett Company, Inc., 63.6% Follow-Through Indicator, 10.9% SensitiveEarnings Reaction History: Lannett Company, Inc., 63.6% Follow-Through Indicator, 10.9% Sensitive
www.nasdaq.com - May 7 at 5:28 PM
BRIEF-Lannett Reports Q3 Adjusted Earnings Per Share $0.80BRIEF-Lannett Reports Q3 Adjusted Earnings Per Share $0.80
www.reuters.com - May 7 at 5:28 PM
Lannett Company, Inc. to Host Earnings CallLannett Company, Inc. to Host Earnings Call
finance.yahoo.com - May 7 at 5:28 PM
Lannett Announces Fiscal 2018 Third-Quarter Financial ResultsLannett Announces Fiscal 2018 Third-Quarter Financial Results
finance.yahoo.com - May 7 at 5:28 PM
Lannett acquires 23 generic drug products from Endo subsidiaryLannett acquires 23 generic drug products from Endo subsidiary
finance.yahoo.com - May 7 at 5:28 PM
BRIEF-Lannett Acquires Portfolio Of Generic Products From Endo InternationalBRIEF-Lannett Acquires Portfolio Of Generic Products From Endo International
www.reuters.com - May 7 at 8:31 AM
Lannett Acquires Portfolio Of Generic Products From Endo InternationalLannett Acquires Portfolio Of Generic Products From Endo International
finance.yahoo.com - May 7 at 8:31 AM
Lannett To Report Fiscal 2018 Third-Quarter Financial Results, Host Conference ...Lannett To Report Fiscal 2018 Third-Quarter Financial Results, Host Conference ...
www.prnewswire.com - May 4 at 5:20 PM
Lannett To Participate At Two Investor Conferences In MayLannett To Participate At Two Investor Conferences In May
finance.yahoo.com - May 3 at 8:28 AM
Lannett To Report Fiscal 2018 Third-Quarter Financial Results, Host Conference Call On Monday, May 7Lannett To Report Fiscal 2018 Third-Quarter Financial Results, Host Conference Call On Monday, May 7
finance.yahoo.com - May 2 at 8:33 AM
BRIEF-Lannett Appoints Patrick Lepore Chairman Of BoardBRIEF-Lannett Appoints Patrick Lepore Chairman Of Board
www.reuters.com - April 30 at 8:35 AM
Lannett Announces Changes To Board Of DirectorsLannett Announces Changes To Board Of Directors
finance.yahoo.com - April 30 at 8:35 AM
Is It Time To Buy Lannett Company Inc (NYSE:LCI) Based Off Its PE Ratio?Is It Time To Buy Lannett Company Inc (NYSE:LCI) Based Off Its PE Ratio?
finance.yahoo.com - April 30 at 8:35 AM
ValuEngine Downgrades Lannett (LCI) to SellValuEngine Downgrades Lannett (LCI) to Sell
www.americanbankingnews.com - April 27 at 10:20 PM
Lannett Co Inc (LCI) Receives Consensus Recommendation of "Hold" from AnalystsLannett Co Inc (LCI) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - April 25 at 5:30 PM
Lannett Co Inc (LCI) Expected to Announce Quarterly Sales of $176.30 MillionLannett Co Inc (LCI) Expected to Announce Quarterly Sales of $176.30 Million
www.americanbankingnews.com - April 25 at 5:53 AM
Lannett (LCI) Scheduled to Post Quarterly Earnings on MondayLannett (LCI) Scheduled to Post Quarterly Earnings on Monday
www.americanbankingnews.com - April 23 at 4:28 AM
Lannett Co Inc (LCI) Expected to Post Earnings of $0.76 Per ShareLannett Co Inc (LCI) Expected to Post Earnings of $0.76 Per Share
www.americanbankingnews.com - April 23 at 3:18 AM
Lannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations OfficerLannett Names Maureen Cavanaugh Senior Vice President And Chief Commercial Operations Officer
finance.yahoo.com - April 20 at 8:38 AM
Lannett (LCI) Upgraded at Zacks Investment ResearchLannett (LCI) Upgraded at Zacks Investment Research
www.americanbankingnews.com - April 19 at 5:50 PM
This Mornings Technical Outlook on Generic Drugs Stocks -- Fibrocell Science, Galectin Therapeutics, Lannett, and ...This Morning's Technical Outlook on Generic Drugs Stocks -- Fibrocell Science, Galectin Therapeutics, Lannett, and ...
www.prnewswire.com - April 18 at 8:29 AM
Lannett (LCI) Upgraded to "Buy" by Zacks Investment ResearchLannett (LCI) Upgraded to "Buy" by Zacks Investment Research
www.americanbankingnews.com - April 17 at 9:49 PM
Lannett (LCI) Lowered to Hold at BidaskClubLannett (LCI) Lowered to Hold at BidaskClub
www.americanbankingnews.com - April 16 at 8:06 PM
Lannett (LCI) Stock Rating Lowered by BidaskClubLannett (LCI) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - April 14 at 12:49 AM
Why Lannett Company Inc (NYSE:LCI) May Not Be As Efficient As Its IndustryWhy Lannett Company Inc (NYSE:LCI) May Not Be As Efficient As Its Industry
finance.yahoo.com - April 13 at 8:37 AM
Lannett (LCI) Lowered to "Strong Sell" at BidaskClubLannett (LCI) Lowered to "Strong Sell" at BidaskClub
www.americanbankingnews.com - April 12 at 6:14 PM
Edited Transcript of LCI presentation 6-Mar-17 7:50pm GMTEdited Transcript of LCI presentation 6-Mar-17 7:50pm GMT
finance.yahoo.com - April 12 at 8:57 AM
Lannett (LCI) Downgraded to "Sell" at Zacks Investment ResearchLannett (LCI) Downgraded to "Sell" at Zacks Investment Research
www.americanbankingnews.com - April 11 at 7:56 AM
Lannett (LCI) Stock Rating Lowered by Zacks Investment ResearchLannett (LCI) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - April 10 at 9:45 AM
Lannett (LCI) Lifted to Buy at ValuEngineLannett (LCI) Lifted to Buy at ValuEngine
www.americanbankingnews.com - April 8 at 11:48 AM
Lannett Company, Inc. (LCI) Expected to Post Quarterly Sales of $176.30 MillionLannett Company, Inc. (LCI) Expected to Post Quarterly Sales of $176.30 Million
www.americanbankingnews.com - April 8 at 5:04 AM
Zacks: Brokerages Anticipate Lannett Company, Inc. (LCI) Will Post Earnings of $0.76 Per ShareZacks: Brokerages Anticipate Lannett Company, Inc. (LCI) Will Post Earnings of $0.76 Per Share
www.americanbankingnews.com - April 6 at 3:06 AM
Lannett (LCI) Raised to "Buy" at ValuEngineLannett (LCI) Raised to "Buy" at ValuEngine
www.americanbankingnews.com - April 1 at 12:08 AM
Lannett (LCI) Raised to "Buy" at Zacks Investment ResearchLannett (LCI) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - March 31 at 4:56 PM

SEC Filings

Lannett (NYSE:LCI) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Lannett (NYSE:LCI) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Lannett (NYSE LCI) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.